NDC 63323-763

Paclitaxel

Paclitaxel

Paclitaxel is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Fresenius Kabi Usa, Llc. The primary component is Paclitaxel.

Product ID63323-763_423bcbc2-3aea-4c53-b93a-d5af7224886e
NDC63323-763
Product TypeHuman Prescription Drug
Proprietary NamePaclitaxel
Generic NamePaclitaxel
Dosage FormInjection, Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2014-08-15
Marketing CategoryANDA / ANDA
Application NumberANDA090130
Labeler NameFresenius Kabi USA, LLC
Substance NamePACLITAXEL
Active Ingredient Strength6 mg/mL
Pharm ClassesMicrotubule Inhibition [PE],Microtubule Inhibitor [EPC]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 63323-763-05

1 VIAL, MULTI-DOSE in 1 CARTON (63323-763-05) > 5 mL in 1 VIAL, MULTI-DOSE
Marketing Start Date2009-03-20
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 63323-763-16 [63323076316]

Paclitaxel INJECTION, SOLUTION
Marketing CategoryANDA
Application NumberANDA077574
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2009-03-20

NDC 63323-763-06 [63323076306]

Paclitaxel INJECTION, SOLUTION
Marketing CategoryANDA
Application NumberANDA090130
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2014-08-15
Marketing End Date2017-01-31

NDC 63323-763-50 [63323076350]

Paclitaxel INJECTION, SOLUTION
Marketing CategoryANDA
Application NumberANDA077574
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2009-03-20

NDC 63323-763-52 [63323076352]

Paclitaxel INJECTION, SOLUTION
Marketing CategoryANDA
Application NumberANDA090130
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2014-08-15
Marketing End Date2017-02-28

NDC 63323-763-05 [63323076305]

Paclitaxel INJECTION, SOLUTION
Marketing CategoryANDA
Application NumberANDA077574
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2009-03-20

NDC 63323-763-17 [63323076317]

Paclitaxel INJECTION, SOLUTION
Marketing CategoryANDA
Application NumberANDA090130
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2014-08-15
Marketing End Date2016-12-31

Drug Details

Active Ingredients

IngredientStrength
PACLITAXEL6 mg/mL

OpenFDA Data

SPL SET ID:f10f730f-6479-4f6a-8edc-fa4bd2140c1b
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 312199
  • UPC Code
  • 0363323763060
  • Pharmacological Class

    • Microtubule Inhibition [PE]
    • Microtubule Inhibitor [EPC]

    Medicade Reported Pricing

    63323076350 PACLITAXEL 300 MG/50 ML VIAL

    Pricing Unit: ML | Drug Type:

    63323076316 PACLITAXEL 100 MG/16.7 ML VIAL

    Pricing Unit: ML | Drug Type:

    63323076305 PACLITAXEL 30 MG/5 ML VIAL

    Pricing Unit: ML | Drug Type:

    NDC Crossover Matching brand name "Paclitaxel" or generic name "Paclitaxel"

    NDCBrand NameGeneric Name
    0703-3213PaclitaxelPaclitaxel
    0703-3216PaclitaxelPaclitaxel
    0703-3217PaclitaxelPaclitaxel
    0703-3218PaclitaxelPaclitaxel
    0703-4764PaclitaxelPaclitaxel
    0703-4766PaclitaxelPaclitaxel
    0703-4767PaclitaxelPaclitaxel
    0703-4768PaclitaxelPaclitaxel
    16714-137PaclitaxelPaclitaxel
    16729-098PaclitaxelPACLITAXEL
    44567-504PaclitaxelPaclitaxel
    44567-505PaclitaxelPaclitaxel
    44567-506PaclitaxelPaclitaxel
    45963-613PaclitaxelPaclitaxel
    47781-593Paclitaxelpaclitaxel
    70860-200PaclitaxelPaclitaxel
    47781-595PaclitaxelPaclitaxel
    47781-594PaclitaxelPaclitaxel
    51991-938PaclitaxelPaclitaxel
    51991-937PaclitaxelPaclitaxel
    51991-936PaclitaxelPaclitaxel
    61703-342PaclitaxelPaclitaxel
    63323-763PaclitaxelPaclitaxel
    67457-449PaclitaxelPaclitaxel
    67457-434PaclitaxelPaclitaxel
    67457-471PaclitaxelPaclitaxel
    70860-215PaclitaxelPaclitaxel
    24979-710Paclitaxel Protein-Bound Particles for Injectable Suspension (Albumin-Bound)Paclitaxel

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.